{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "marketState": "REGULAR", "epsCurrentYear": -0.28, "priceEpsCurrentYear": -2.27, "sharesOutstanding": 226427008, "bookValue": 0.335, "fiftyDayAverage": 0.78862, "fiftyDayAverageChange": -0.15302002, "fiftyDayAverageChangePercent": -0.19403519, "twoHundredDayAverage": 1.4722135, "twoHundredDayAverageChange": -0.83661354, "twoHundredDayAverageChangePercent": -0.56826913, "marketCap": 143916992, "forwardPE": 2.5424, "priceToBook": 1.8973134, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.6 - Hold", "tradeable": false, "cryptoTradeable": false, "exchange": "FRA", "shortName": "OCUGEN INC", "longName": "Ocugen, Inc.", "messageBoardId": "finmb_303874231", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "regularMarketChangePercent": -10.579632, "regularMarketPrice": 0.6356, "market": "dr_market", "esgPopulated": false, "firstTradeDateMilliseconds": 1420182000000, "regularMarketChange": -0.07520002, "regularMarketTime": 1683871252, "regularMarketDayHigh": 0.6356, "regularMarketDayRange": "0.6356 - 0.6356", "regularMarketDayLow": 0.6356, "regularMarketVolume": 2357, "regularMarketPreviousClose": 0.7108, "bid": 0.64, "ask": 0.6554, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 0.6356, "averageDailyVolume3Month": 1766, "averageDailyVolume10Day": 3209, "fiftyTwoWeekLowChange": 0.032999992, "fiftyTwoWeekLowChangePercent": 0.054762684, "fiftyTwoWeekRange": "0.6026 - 3.1", "fiftyTwoWeekHighChange": -2.4643998, "fiftyTwoWeekHighChangePercent": -0.7949677, "fiftyTwoWeekLow": 0.6026, "fiftyTwoWeekHigh": 3.1, "earningsTimestamp": 1683289800, "earningsTimestampStart": 1691065800, "earningsTimestampEnd": 1691411400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.34, "epsForward": 0.25, "priceHint": 4, "symbol": "2H51.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "263 Great Valley Parkway", "address2": "Suite 160", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 328 4701", "website": "https://www.ocugen.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410 and OCU410ST for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. It has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.", "fullTimeEmployees": 84, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shankar  Musunuri M.B.A., MBA, Ph.D.", "age": 58, "title": "Co-Founder, Chairman & CEO", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 1201460, "fmt": "1.2M", "longFmt": "1,201,460"}, "exercisedValue": {"raw": 1257295, "fmt": "1.26M", "longFmt": "1,257,295"}, "unexercisedValue": {"raw": 263200, "fmt": "263.2k", "longFmt": "263,200"}}, {"maxAge": 1, "name": "Dr. Uday B. Kompella Ph.D.", "age": 55, "title": "Co-founder & Independent Director", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 56724, "fmt": "56.72k", "longFmt": "56,724"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Quan Anh Vu", "age": 49, "title": "CFO, Chief Bus. Officer & Principal Accounting Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Arun  Upadhyay Ph.D.", "age": 40, "title": "Chief Scientific Officer and Head of Research, Devel. & Medical", "yearBorn": 1982, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Tiffany J. Hamilton M.B.A.", "title": "Head of Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Zara  Gaudioso", "title": "AVP, Head of HR & Chief of Staff", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Michael  Shine M.B.A.", "title": "Sr. VP of Commercial", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jyothy  Pillai M.S.", "title": "Head of Regulatory & Quality", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Huma  Qamar CMI, M.D., M.P.H.", "title": "Head of Clinical Devel. & Medical Affairs", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 8, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}